Skip to content
DraconiticResearch
Search Sources API
186,123 studies31 sourcesUpdated 40 min ago
Peer-reviewedLicence not statedCardiovascular Research

Long-term mavacamten exposure reduces force and sarcomere density in a human induced pluripotent stem cell–derived model of hypertrophic cardiomyopathy

  • Marianna Langione
  • Lucrezia Giammarino
  • Roberto Semeraro
  • Beatrice Scellini
  • Sonette Steczina
  • Valentina Spinelli
  • Elema Martelli
  • Irma Della Corte
  • Camilla Olianti
  • Alberto Magi
  • Leonardo Sacconi
  • Elisabetta Cerbai
7 more authors
  • Michael Regnier
  • Iacopo Olivotto
  • Chiara Tesi
  • Corrado Poggesi
  • Raffaele Coppini
  • Cecilia Ferrantini
  • Josè Manuel Pioner
Open at sourcePDFDOICite

Related

  1. Managing a mavacamten non-responder in obstructive hypertrophic cardiomyopathy: A case report
    Smita Scholtz, Felix Langkamp, Volker Rudolph +2
    Journal of cardiology casesPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Mavacamten shows broad benefit in human and mouse models of MYBPC3-related hypertrophic cardiomyopathy
    Laura Sen-Martín, Ángel Fernández-Trasancos, Miguel Á. López-Unzu +34
    Nature Cardiovascular ResearchPeer-reviewedPublisher termsFull textCardiovascular medicineHAL
  3. Mavacamten improves energy balance in a pre-clinical model of RASopathy-associated hypertrophic cardiomyopathy
    Andrea Ruiz-Velasco, Charlène Jouve, Lucille Deshayes +3
    Pediatric ResearchPeer-reviewedCC BY-NC-SA 4.0Full text1 citedGeneral biologyCardiovascular medicineHAL
  4. Real-World Implementation and Clinical Outcomes of Mavacamten in an Underserved Urban Cohort With Obstructive Hypertrophic Cardiomyopathy
    J. Bock, S. Murthy, A. L. Schenone +1
    medRxivPreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
  5. Clinical effectiveness of mavacamten on cardiac function and disease-related indicators in patients with obstructive hypertrophic cardiomyopathy
    Ya-Nan Shi, Jia-Jia Huang, Hong-Zhi Liu +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{langione2026longterm,
  title = {{Long-term mavacamten exposure reduces force and sarcomere density in a human induced pluripotent stem cell–derived model of hypertrophic cardiomyopathy}},
  author = {Marianna Langione and Lucrezia Giammarino and Roberto Semeraro and Beatrice Scellini and Sonette Steczina and Valentina Spinelli and Elema Martelli and Irma Della Corte and Camilla Olianti and Alberto Magi and Leonardo Sacconi and Elisabetta Cerbai and Michael Regnier and Iacopo Olivotto and Chiara Tesi and Corrado Poggesi and Raffaele Coppini and Cecilia Ferrantini and Josè Manuel Pioner},
  journal = {Cardiovascular Research},
  year = {2026},
  month = aug,
  doi = {10.1093/cvr/cvag159},
  url = {https://hal.science/hal-05795702v1},
}
RIS
TY  - JOUR
TI  - Long-term mavacamten exposure reduces force and sarcomere density in a human induced pluripotent stem cell–derived model of hypertrophic cardiomyopathy
AU  - Marianna Langione
AU  - Lucrezia Giammarino
AU  - Roberto Semeraro
AU  - Beatrice Scellini
AU  - Sonette Steczina
AU  - Valentina Spinelli
AU  - Elema Martelli
AU  - Irma Della Corte
AU  - Camilla Olianti
AU  - Alberto Magi
AU  - Leonardo Sacconi
AU  - Elisabetta Cerbai
AU  - Michael Regnier
AU  - Iacopo Olivotto
AU  - Chiara Tesi
AU  - Corrado Poggesi
AU  - Raffaele Coppini
AU  - Cecilia Ferrantini
AU  - Josè Manuel Pioner
PY  - 2026
DA  - 2026/08/24
JO  - Cardiovascular Research
DO  - 10.1093/cvr/cvag159
UR  - https://hal.science/hal-05795702v1
SN  - 0008-6363
ER  -